NYPOZI
Formula & Concentration
NYPOZI – filgrastim-txid 300 mcg/0.5 mL injection syringe
Manufacturer
Cipla USA Inc.
Indications
Severe chronic neutropenia; cyclic neutropenia; peripheral mobilization of hematopoietic stem cells; drug-induced neutropenia; prevention of neutropenia from cancer chemotherapy; chemotherapy-induced neutropenia; AIDS-associated neutropenia; myeloid engraftment enhancement; hematopoietic syndrome of acute radiation syndrome; neutropenia secondary to AML treatment; myelodysplastic syndrome; congenital neutropenia; idiopathic neutropenia
Shelf Life and Storage
Fridge (2-8°C)




